Ginkgo diterpene lactone meglumine injection
Sponsors
Beijing Tiantan Hospital, RenJi Hospital, Shanghai Yueyang Integrated Medicine Hospital
Conditions
Ischemic StrokeIschemic Stroke, Acute
Phase 2
A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.
CompletedNCT02526225
Start: 2016-02-01End: 2019-08-31Updated: 2023-03-30
Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke
NCT03219645
Start: 2017-07-15End: 2017-12-31Target: 40Updated: 2017-07-17
Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke
NCT05531942
Start: 2021-01-01End: 2023-11-01Target: 70Updated: 2023-07-14
The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke
NCT05663307
Start: 2021-01-01End: 2023-12-01Target: 80Updated: 2022-12-29